Skip to main content

Rylaze

NDC 68727-900 · Jazz Pharmaceuticals, Inc.

Generic nameasparaginase erwinia chrysanthemi (recombinant)-rywn

Dosage formINJECTION

RouteINTRAMUSCULAR

Active ingredient(s)ASPARAGINASE

Strength20 mg/mL

Pharmacologic classAsparaginase [CS], Asparagine-specific Enzyme [EPC]

Marketing categoryBLA

Packages

68727-900-03 — 3 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03) / .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01)

Billed under HCPCS

J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg Medicare Part B payment limit (ASP + 6%): $58.70

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels